Zürcher Nachrichten - US tycoon opens Africa's first start-to-finish Covid-19 jab plant

EUR -
AED 4.295669
AFN 81.659805
ALL 97.59679
AMD 449.318813
ANG 2.093003
AOA 1072.451874
ARS 1475.644248
AUD 1.794058
AWG 2.10514
AZN 1.983214
BAM 1.949112
BBD 2.359903
BDT 142.594381
BGN 1.954148
BHD 0.440826
BIF 3482.281201
BMD 1.169522
BND 1.494286
BOB 8.076288
BRL 6.389332
BSD 1.168889
BTN 100.107506
BWP 15.605056
BYN 3.825008
BYR 22922.632738
BZD 2.347764
CAD 1.600134
CDF 3374.071364
CHF 0.933318
CLF 0.028812
CLP 1105.736529
CNY 8.391203
CNH 8.40049
COP 4728.868963
CRC 590.877604
CUC 1.169522
CUP 30.992335
CVE 109.890756
CZK 24.67598
DJF 208.146476
DKK 7.460604
DOP 70.129369
DZD 151.646348
EGP 58.102794
ERN 17.542831
ETB 162.211399
FJD 2.631132
FKP 0.857659
GBP 0.86313
GEL 3.169688
GGP 0.857659
GHS 12.184193
GIP 0.857659
GMD 83.619991
GNF 10137.475837
GTQ 8.983406
GYD 244.543456
HKD 9.18069
HNL 30.56313
HRK 7.53628
HTG 153.403634
HUF 399.99646
IDR 19032.334497
ILS 3.924764
IMP 0.857659
INR 100.31482
IQD 1531.146256
IRR 49266.117322
ISK 142.635147
JEP 0.857659
JMD 186.55467
JOD 0.829203
JPY 171.878229
KES 151.020046
KGS 102.274813
KHR 4692.97748
KMF 491.786276
KPW 1052.567626
KRW 1605.56683
KWD 0.357404
KYD 0.974099
KZT 607.326113
LAK 25179.817077
LBP 104723.56736
LKR 351.373364
LRD 234.357883
LSL 20.788303
LTL 3.453295
LVL 0.707432
LYD 6.313499
MAD 10.526351
MDL 19.782881
MGA 5162.330898
MKD 61.484377
MMK 2455.076978
MNT 4197.195447
MOP 9.451156
MRU 46.419912
MUR 52.757403
MVR 18.008227
MWK 2026.749695
MXN 21.884904
MYR 4.959987
MZN 74.80251
NAD 20.787772
NGN 1789.988932
NIO 43.013513
NOK 11.839768
NPR 160.173773
NZD 1.953501
OMR 0.449676
PAB 1.1688
PEN 4.167407
PGK 4.901308
PHP 66.212533
PKR 332.295336
PLN 4.245831
PYG 9315.275919
QAR 4.261188
RON 5.081113
RSD 117.18491
RUB 91.423841
RWF 1688.991301
SAR 4.386252
SBD 9.750217
SCR 16.501705
SDG 702.296742
SEK 11.172819
SGD 1.498561
SHP 0.919061
SLE 26.316673
SLL 24524.297511
SOS 668.019283
SRD 43.650656
STD 24206.745769
SVC 10.22717
SYP 15205.971824
SZL 20.779877
THB 38.148672
TJS 11.226754
TMT 4.105022
TND 3.408704
TOP 2.739135
TRY 46.809718
TTD 7.929858
TWD 34.070283
TZS 3081.915215
UAH 48.821633
UGX 4201.583321
USD 1.169522
UYU 46.930175
UZS 14816.540825
VES 130.147048
VND 30565.459521
VUV 138.967301
WST 3.205062
XAF 653.725086
XAG 0.032128
XAU 0.000355
XCD 3.160692
XDR 0.812384
XOF 653.730656
XPF 119.331742
YER 283.199244
ZAR 20.881174
ZMK 10527.103931
ZMW 28.313848
ZWL 376.585632
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US biotech billionaire Patrick Soon-Shiong on Wednesday opened a plant in Cape Town that will be the first in Africa to produce Covid-19 vaccines from start to finish.

Text size:

The factory should churn out its first vials of second-generation coronavirus vaccine "within the year" and produce a billion doses annually by 2025, Soon-Shiong said.

The plant will be South Africa's third Covid vaccine-manufacturing facility but the first in the continent to make the formula across every stage, rather than producing it from semi-finished batches.

With just 10.9 percent of the 1.3 billion people fully vaccinated, Africa is the least vaccinated continent in the world. This compares with approximately 63 percent in the US and around 70 percent in Europe.

Africa currently manufactures less than one percent of all vaccines administered on the continent, according to the World Health Organization (WHO).

South African President Cyril Ramaphosa, speaking at the inaugural event, hailed the plant as a sign of African self-reliance.

"Africa should no longer be the last in line to access vaccines against pandemics, Africa should no longer go cap in hand to the Western world begging and begging for vaccines," Ramaphosa said.

"We will stand on our own," he vowed, "without the shackles of colonial thinking."

He thanked Soon-Shiong, a South African-born and now United States-based doctor-turned-entrepreneur -- for returning "home" to invest in vaccine production.

Born in South Africa to Chinese parents and now a US citizen, the billionaire said the launch was "one of the momentous moments of my life -- this is a homecoming."

- T-cell vaccine -

After making a fortune by inventing a cancer drug, he founded NantWorks, a California-based startup in healthcare, biotech and artificial intelligence, in 2007.

Production at the state-of-the-art vaccine-manufacturing campus in Cape Town's Brackengate industrial area will be a collaborative effort between NantWorks, South African research institutions and four local universities.

"We have now developed this SN (spike nucleic) T-cell vaccine, a second-generation vaccine, and we want to manufacture this in Africa, for Africa, and export it to the world," Soon-Shiong said.

The vaccine is being developed "all the way from scratch", with self-amplifying RNA (ribonucleic acid) drug substance, to "full finish", the doctor said.

Johnson & Johnson has an operational "fill-and-finish" plant in South Africa, and Pfizer/BioNTech have partnered with Biovac to bottle their mRNA vaccine starting this year.

"We want to migrate from just doing 'fill and finish', to wanting to manufacture the drug substance ourselves," Ramaphosa said.

Meantime, a South African biotech consortium is working on a pilot project to tweak Moderna's mRNA formula, and prototype shots could be available for trial this year.

South Africa and India have been lobbying the World Trade Organization to temporarily suspend intellectual property rights so that Covid-19 vaccines are accessible to poorer countries.

The billionaire's family foundation, along with the Rockefeller Foundation, the US National Institutes of Health, the European Commission and the Bill & Melinda Gates Foundation, have raised more than one billion rand ($65 million, 57 million euros) to fund the project.

Soon-Shiong says that another $195 million will need to be raised to develop the new plant, which will also produce cancer vaccines.

The NantWorks project will also work on cell-based immunotherapies that could lead to new cancer vaccines and treatments.

L.Muratori--NZN